A.G. Breitenstein ’93, founder of the direct-to-consumer health startup for LGBTQ patients “Folx”, raised twenty-five million dollars in funding. The company made its debut in December, and this new funding will allow Folx to roll out at-home lab kits, STI testing, ED medications and pre-exposure prophylaxis (PrEP). Looking to the future, Breitenstein plans to work with the new administration to continue providing aid to the LGBTQ community after this public health emergency passes.

---